← Back to directory

Christof von Kalle

Researcher Next ID · RN-017053

Researcher · Biochemistry, Genetics and Molecular Biology

Luxembourg Institute of Health

, Luxembourg

Not currently recruitingFunding unknown
Works count
602
Citation count
62,803
H-index
111
i10-index
292

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Virus-based gene therapy research
CRISPR and Genetic Engineering
Cancer Genomics and Diagnostics
CAR-T cell therapy research
RNA Interference and Gene Delivery

Publications

  • Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment

    Cell · 2020 · 10.1016/j.cell.2020.08.001

  • Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy

    Science · 2009 · 10.1126/science.1171242

  • Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients

    Journal of Clinical Investigation · 2008 · 10.1172/jci35798

  • LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1

    Science · 2003 · 10.1126/science.1088547

  • A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency

    New England Journal of Medicine · 2003 · 10.1056/nejm200301163480314

Current projects

    No projects listed.